Beta Drugs Ltd.

NSE : BETA

Add Alert

Add Watchlist

₹1926.5

11.5 (0.6%) - 18 Aug 2025 04:28 PM

NSE : BETA

About Company

Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases. Beta Drugs is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Market Cap. ₹ 1,945 Cr.

52 Week - High/Low ₹ 0/0

P/E Ratio 46.70

P/B Ratio 15.04

Enterprise Value ₹ 1,733 Cr.

ROE % 20.67

RSI Value 72.73

EMA 50 1769.97

EMA 200 1732.76

Market Cap. ₹ 1,945 Cr.

52 Week - High/Low ₹ 0/0

P/E Ratio 22.13